ELIAZ ISAAC has a total of 17 patent applications. Its first patent ever was published in 2006. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, medical technology and measurement are VALEANT PHARMACEUTICALS NORTH, CERECOR INC and ORIGIN INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Canada | 2 | |
#4 | South Africa | 2 | |
#5 | Australia | 1 | |
#6 | Brazil | 1 | |
#7 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Measurement | |
#4 | Biotechnology | |
#5 | Chemical engineering |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Syringes | |
#3 | Medical preparations | |
#4 | Peptides | |
#5 | Analysing materials | |
#6 | Medical purpose containers | |
#7 | Chemical or physical processes |
# | Name | Total Patents |
---|---|---|
#1 | Eliaz Isaac | 16 |
Publication | Filing date | Title |
---|---|---|
US2020360426A1 | Protocol and composition for suppression of allergic responses | |
US2014094763A1 | Reduction of galectin-3 levels by plasmapheresis | |
AU2012348311A1 | Reduction of galectin-3 levels by plasmapheresis | |
US2011294755A1 | Binding of galectin-3 by low molecular weight pectin | |
US2012171228A1 | Synergistic combination of honokiol and modified citrus pectin in cancer therapy | |
US2007049551A1 | Method for enhancing mammalian immunological function | |
US2007167395A1 | Compositions and methods for treating diabetes |